Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during July 2025 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018'.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec has filed a routine compliance report listing shares dematerialized during July 2025. Only 1,000 shares were newly dematerialized during the month, transferred from the company's Suspense Escrow Demat Account on July 8, 2025. Total dematerialized shares stood at 6,10,97,525 as of July 31, 2025, split between NSDL (5,19,29,477) and CDSL (91,68,048), a marginal increase of 1,000 shares from the June 30, 2025 figure. The filing was made by Skyline Financial Services, the company's Registrar and Transfer Agent.
This is a standard regulatory disclosure with negligible activity and no material impact on shareholders or stock price. No corporate action is involved.